Depression Clinical Trials

Showing 861-880 of 3,654 trials

Scopolamine in Bipolar Depression

NCT04211961

This is a single-site, randomised, double-blind, placebo-controlled, parallel, phase IIb clinical trial. The primary objective of the SCOPE-BD study is to investigate the efficacy and safety of IV Scopolamine, compared to placebo, in reducing severity of depression in individuals with bipolar disorder who are experiencing a depressive episode of at least moderate severity

Bipolar Disorder Depression

Dr. Brian Hallahan55 participantsStarted Mar 2021

Galway, County Galway, Ireland

COMPLETEDPhase 2

A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression

NCT02918318

The purpose of this study is to evaluate the efficacy of fixed dosed intranasal esketamine compared to intranasal placebo, as an add-on to an oral antidepressant in Japanese participants with treatment-resistant depression (TRD), in improving depressive symptoms.

Depression

Janssen Pharmaceutical K.K.202 participantsStarted Dec 2016

Akita, Japan • Fukui-shi, Japan • Fukuoka, Japan +40 more locations

Scopolamine in Bipolar Depression

A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression

Related Searches

Feasibility of Modified Mindfulness Training on Antenatal Depression and Perceived Stress in Pregnant Women With Male Child Preference

A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

New Mothers Alpha-Stim

Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents With Anxiety and Depression

MRI-Guided High-Definition Transcranial Direct Current Stimulation (tDCS) for Depression

Generated AI-informed Intervention (Emohaa) vs Group ACT vs WL on Emotional Distress

Does Psilocybin Require Psychedelic Effects to Treat Depression?

Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)

Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD

Clinical and Psychosocial Characteristics of Adolescent Patients With Non-Suicidal Self-Injury

Post-Stroke Optimization of Walking Using Explosive Resistance

A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive Disorder

Evaluating the Feasibility of a School-based Stepped Care Program for Internalizing Symptoms in Adolescents in Pakistan

CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)

From Fear to Purpose ACT Protocol. Implications of Death Anxiety in Depression and Anxiety Symptoms.

Psychological Effect of Explicit Recall After Sedation (PEERS)